Chris Sherlaw-Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chris Sherlaw-Johnson has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Naomi J. Fulop
Research Department of Behavioural Science and Health, Institute of Epidemiology and Healthcare University College London London UK
17 shared publications - Pei Li Ng
Research Department of Behavioural Science and Health, Institute of Epidemiology and Healthcare University College London London UK
15 shared publications - Holly Walton
Department of Behavioural Science and Health, Institute of Epidemiology and Healthcare, University College London, London, UK
13 shared publications - Stephen Morris
University of Cambridge, Cambridge, UK
12 shared publications - Sonila M. Tomini
Global Business School for Health, University College London, London, UK
11 shared publications - Theo Georghiou
The Nuffield Trust
11 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Elsevier in SSRN Electronic Journal
Economic Evaluation of Artificial Intelligence Deployment in Lung Cancer Chest Diagnostic Imaging
Background: Lung cancer imposes a heavy burden on the NHS, where rising imaging demand and workforce shortages delay early diagnosis. Despite early promise, real-world cost-effectiveness evidence for artificial intelligence (AI) deployment remains limited.Methods: We evaluated the cost-effectiveness of AI deployment in chest diagnostic imaging versus standard practice for patients referred with potential lung cancer (LC). A short-term decision-tree model evaluated the cost-utility from an NHS and Personal Social Services perspective.Costs and health outcomes were estimated using data from ten NHS England radiology services and published literature, while chest X-ray sensitivity and specificity estimates were derived from a single NHS trust. Cost-effectiveness was assessed using incremental cost-effectiveness ratios, and incremental net monetary benefit (INMBs).Findings: AI deployment showed no evidence of improved health outcomes versus standard practice (incremental quality-adjusted life years [QALYs], <0.001), but reduced costs by £2.05 per patient. The INMB was positive at thresholds £15,000/QALY (£3.62), £20,000/QALY (£4.14) and £30,000/QALY (£5.19) respectively.Chest X-ray specificity was the main driver of incremental costs and QALYs in sensitivity analyses. AI remained less costly and equally effective in all scenarios assessed including hypothetical autonomous AI reporting of high confidence normal images.Interpretation: This evaluation provides early, real‑world evidence consistent with AI deployment in chest imaging for suspected LC being cost-effective through modest cost savings rather than health gains. However, the uncontrolled pre-post design limits causal inference, and concurrent system changes may have influenced results. Scenario analyses suggest that autonomous reporting and shared licensing could deliver additional efficiencies and cost savings.
- 20 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEconomic Evaluation of Artificial Intelligence Deployment in Lung Cancer Chest Diagnostic Imaging
Background: Lung cancer imposes a heavy burden on the NHS, where rising imaging demand and workforce shortages delay early diagnosis. Despite early promise, real-world cost-effectiveness evidence for artificial intelligence (AI) deployment remains limited.Methods: We evaluated the cost-effectiveness of AI deployment in chest diagnostic imaging versus standard practice for patients referred with potential lung cancer (LC). A short-term decision-tree model evaluated the cost-utility from an NHS and Personal Social Services perspective.Costs and health outcomes were estimated using data from ten NHS England radiology services and published literature, while chest X-ray sensitivity and specificity estimates were derived from a single NHS trust. Cost-effectiveness was assessed using incremental cost-effectiveness ratios, and incremental net monetary benefit (INMBs).Findings: AI deployment showed no evidence of improved health outcomes versus standard practice (incremental quality-adjusted life years [QALYs], <0.001), but reduced costs by £2.05 per patient. The INMB was positive at thresholds £15,000/QALY (£3.62), £20,000/QALY (£4.14) and £30,000/QALY (£5.19) respectively.Chest X-ray specificity was the main driver of incremental costs and QALYs in sensitivity analyses. AI remained less costly and equally effective in all scenarios assessed including hypothetical autonomous AI reporting of high confidence normal images.Interpretation: This evaluation provides early, real‑world evidence consistent with AI deployment in chest imaging for suspected LC being cost-effective through modest cost savings rather than health gains. However, the uncontrolled pre-post design limits causal inference, and concurrent system changes may have influenced results. Scenario analyses suggest that autonomous reporting and shared licensing could deliver additional efficiencies and cost savings.
- Open Access
- 2 October 2026
- Published by Elsevier in SSRN Electronic Journal
What Is the Impact of Introducing AI for Chest X-Ray Diagnostics on the Processing of Results and Their Follow-Up? A Real-World, Mixed Methods Evaluation
Background: The English NHS has prioritized introducing Artificial Intelligence (AI) for chest radiology diagnostics. However, there is little ‘real-world’ evidence on how AI tools work in clinical practice.Methods: Observational, mixed-methods rapid evaluation of impact of AI on processing and follow up of chest x-ray (CXR) results. We triangulated quantitative data from eight NHS sites’ radiology information systems (n=460,663 scans), and qualitative interview data (n=27, including clinicians, IT staff, project managers, and AI suppliers) from four of these eight sites.Findings: Prioritising CXR images interpreted as abnormal by AI saw faster clinical reporting of suspected cancers than clinically normal or mildly abnormal cases (site-level odds ratios ranged from 1.34 to 6.09, all p≤0.01). Impact on proportions of abnormal x-rays needing follow-up varied: 2/8 sites showed significant increases, while 3/8 showed significant decreases. There was no significant increase in numbers of CT scans conducted within three days of CXR reports. Qualitative analysis supported quantitative findings on impact and identified potential contributing factors, e.g. preexisting activity levels and backlogs, additional investments in diagnostic pathways, and readers’ experience levels.Interpretation: Through worklist prioritisation and clinical decision support, AI may contribute to improved radiology workflows. However, varied impact of AI tools across sites suggests that clinical and organisational context and implementation approaches can influence the extent of impact.
- 2 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessWhat Is the Impact of Introducing AI for Chest X-Ray Diagnostics on the Processing of Results and Their Follow-Up? A Real-World, Mixed Methods Evaluation
Background: The English NHS has prioritized introducing Artificial Intelligence (AI) for chest radiology diagnostics. However, there is little ‘real-world’ evidence on how AI tools work in clinical practice.Methods: Observational, mixed-methods rapid evaluation of impact of AI on processing and follow up of chest x-ray (CXR) results. We triangulated quantitative data from eight NHS sites’ radiology information systems (n=460,663 scans), and qualitative interview data (n=27, including clinicians, IT staff, project managers, and AI suppliers) from four of these eight sites.Findings: Prioritising CXR images interpreted as abnormal by AI saw faster clinical reporting of suspected cancers than clinically normal or mildly abnormal cases (site-level odds ratios ranged from 1.34 to 6.09, all p≤0.01). Impact on proportions of abnormal x-rays needing follow-up varied: 2/8 sites showed significant increases, while 3/8 showed significant decreases. There was no significant increase in numbers of CT scans conducted within three days of CXR reports. Qualitative analysis supported quantitative findings on impact and identified potential contributing factors, e.g. preexisting activity levels and backlogs, additional investments in diagnostic pathways, and readers’ experience levels.Interpretation: Through worklist prioritisation and clinical decision support, AI may contribute to improved radiology workflows. However, varied impact of AI tools across sites suggests that clinical and organisational context and implementation approaches can influence the extent of impact.
- Open Access
- 1 March 2026
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- p. 1-42
Implementing artificial intelligence in chest diagnostics for lung disease: A mixed-methods evaluation
Background: Artificial intelligence tools simulate aspects of human intelligence. Policy and research highlight artificial intelligence’s potential to support delivery of radiology pathways. In 2023, National Health Service (NHS) England invested £21M to deploy artificial intelligence diagnostic tools for chest X-ray and chest computed tomography in 66 NHS Trusts. Little is known about how artificial intelligence tools are implemented in practice, staff experience of these tools, and their effectiveness and cost. Objectives: Evaluate evidence on artificial intelligence tools within radiology internationally. Evaluate implementation of artificial intelligence for chest diagnostics in England. Investigate how effectiveness and cost-effectiveness of artificial intelligence for chest diagnostics can be measured. Methods: Ten-month mixed-methods study (rapid scoping review and empirical study comprising staff interviews, observations and documentary analysis). Findings were analysed using rapid assessment procedures, drawing on qualitative, quantitative and health economic approaches. Our evaluation was also designed to inform phase 2 of our study. Findings: The review included 114 articles on artificial intelligence use in radiology, internationally. Empirical work included 51 staff interviews, 57 observations and 166 documents from 10/11 of the networks and 6/66 trusts implementing artificial intelligence tools. Our review found evidence gaps, including real-world implementation of artificial intelligence tools; patient and carer experiences; impact on inequalities, sustainability and wider systems; and cost-effectiveness. Artificial intelligence for chest diagnostics was implemented in various ways, with different aims, pathways and approaches. Implementation takes time due to multiple activities related to planning, procurement, preparation for deployment, monitoring and evaluation. These tasks – technical and social – required time and resource, including a wide range of stakeholders and expertise. As of November 2024, 24/66 trusts had implemented artificial intelligence tools in practice. Implementation barriers included time, resources, challenges navigating processes and adapting these to local contexts. Facilitators included stakeholder engagement and support. Network and trust ability to evaluate service impact was influenced by factors such as data availability, data linkage, resources and capacity. Factors varied across implementation stages. Our findings indicated multiple data sources that may support measurement of effectiveness and cost-effectiveness within the English National Health Service. However, limitations to data availability need to be addressed. Limitations: Our rapid timeline meant we could not interview patients, carers, and several staff groups at trust and national levels. Delayed deployment meant we could not study implementation in practice or staff experiences. Future work: Should address real-world implementation, adaptation, and sustainability of artificial intelligence tools; impact of artificial intelligence on care, outcomes, and cost-effectiveness; and staff, patient, and carer experiences of artificial intelligence in practice. We will study these issues in phase 2 of our evaluation. Conclusions: Artificial intelligence tools may support effective, efficient chest diagnostics services. However, several factors should be considered when implementing and monitoring artificial intelligence tools. Implementation and monitoring may be improved through allowing sufficient time for procurement and preparation for deployment or extending capacity to speed completion of these tasks, early and ongoing stakeholder engagement, sufficient resourcing, dedicated expertise and clinical champions, simplifying governance processes, and improving data capacity. Parallels with learning from implementing other innovations suggests that artificial intelligence tools may not offer straightforward solutions anticipated by services and policy-makers. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme as award number NIHR167339.
- 1 March 2026
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- p. 1-42
Open AccessImplementing artificial intelligence in chest diagnostics for lung disease: A mixed-methods evaluation
Background: Artificial intelligence tools simulate aspects of human intelligence. Policy and research highlight artificial intelligence’s potential to support delivery of radiology pathways. In 2023, National Health Service (NHS) England invested £21M to deploy artificial intelligence diagnostic tools for chest X-ray and chest computed tomography in 66 NHS Trusts. Little is known about how artificial intelligence tools are implemented in practice, staff experience of these tools, and their effectiveness and cost. Objectives: Evaluate evidence on artificial intelligence tools within radiology internationally. Evaluate implementation of artificial intelligence for chest diagnostics in England. Investigate how effectiveness and cost-effectiveness of artificial intelligence for chest diagnostics can be measured. Methods: Ten-month mixed-methods study (rapid scoping review and empirical study comprising staff interviews, observations and documentary analysis). Findings were analysed using rapid assessment procedures, drawing on qualitative, quantitative and health economic approaches. Our evaluation was also designed to inform phase 2 of our study. Findings: The review included 114 articles on artificial intelligence use in radiology, internationally. Empirical work included 51 staff interviews, 57 observations and 166 documents from 10/11 of the networks and 6/66 trusts implementing artificial intelligence tools. Our review found evidence gaps, including real-world implementation of artificial intelligence tools; patient and carer experiences; impact on inequalities, sustainability and wider systems; and cost-effectiveness. Artificial intelligence for chest diagnostics was implemented in various ways, with different aims, pathways and approaches. Implementation takes time due to multiple activities related to planning, procurement, preparation for deployment, monitoring and evaluation. These tasks – technical and social – required time and resource, including a wide range of stakeholders and expertise. As of November 2024, 24/66 trusts had implemented artificial intelligence tools in practice. Implementation barriers included time, resources, challenges navigating processes and adapting these to local contexts. Facilitators included stakeholder engagement and support. Network and trust ability to evaluate service impact was influenced by factors such as data availability, data linkage, resources and capacity. Factors varied across implementation stages. Our findings indicated multiple data sources that may support measurement of effectiveness and cost-effectiveness within the English National Health Service. However, limitations to data availability need to be addressed. Limitations: Our rapid timeline meant we could not interview patients, carers, and several staff groups at trust and national levels. Delayed deployment meant we could not study implementation in practice or staff experiences. Future work: Should address real-world implementation, adaptation, and sustainability of artificial intelligence tools; impact of artificial intelligence on care, outcomes, and cost-effectiveness; and staff, patient, and carer experiences of artificial intelligence in practice. We will study these issues in phase 2 of our evaluation. Conclusions: Artificial intelligence tools may support effective, efficient chest diagnostics services. However, several factors should be considered when implementing and monitoring artificial intelligence tools. Implementation and monitoring may be improved through allowing sufficient time for procurement and preparation for deployment or extending capacity to speed completion of these tasks, early and ongoing stakeholder engagement, sufficient resourcing, dedicated expertise and clinical champions, simplifying governance processes, and improving data capacity. Parallels with learning from implementing other innovations suggests that artificial intelligence tools may not offer straightforward solutions anticipated by services and policy-makers. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme as award number NIHR167339.
- Open Access
- 30 January 2026
- Published by SAGE Publications in Journal of Health Services Research & Policy
- Vol. 31 (3) , 161-172
Staff experiences of implementing patient-initiated follow-up (PIFU) in the NHS in England: findings from a rapid qualitative evaluation
Objectives: The NHS in England has introduced various innovations to keep up with the growing demand for elective care, one of which is patient-initiated follow-up (PIFU). This evaluation sought to understand staff experiences of implementing PIFU. Methods: We conducted a rapid qualitative service evaluation between June 2022 and July 2023, based on semi-structured interviews (n = 36) with operational/managerial and clinical NHS staff from five English NHS Trusts, and an online workshop with 21 additional members of staff from the English NHS. We drew on the Non-adoption, Abandonment, Scale-up, Spread and Sustainability (NASSS) framework to structure qualitative data collection and analysis and to generate new insights into the adoption of the innovation of PIFU. Results: We found that implementation of PIFU affected staff roles, workload, and job satisfaction. Levels of PIFU uptake, and experience with similar models, affected the extent to which participants experienced the impact of PIFU. How PIFU was implemented varied. Some staff saw changes in their role because of new administrative demands, safety-netting procedures (such as proactive measures by specialty teams to mitigate the risk of patients not initiating appointments when necessary), and selection of suitable patients. PIFU was felt by some staff to increase, and by others to decrease, workload. PIFU affected intensity of work, interrelated with other factors such as the size of waiting lists, and conditions experienced by patients. Whether staff were satisfied with PIFU related to its impact on their role and workload. Satisfaction was also affected by whether staff believed PIFU delivered benefits for patients, and by the aims they felt were driving rollout. Conclusion: PIFU can significantly affect the experiences of staff and change staff roles and workload. However, the impact of PIFU is not uniform. Staff perspectives on PIFU from all parts of the health system should be better understood and considered during pathway design.
- 30 January 2026
- Published by SAGE Publications in Journal of Health Services Research & Policy
- Vol. 31 (3) , 161-172
Open AccessStaff experiences of implementing patient-initiated follow-up (PIFU) in the NHS in England: findings from a rapid qualitative evaluation
Objectives: The NHS in England has introduced various innovations to keep up with the growing demand for elective care, one of which is patient-initiated follow-up (PIFU). This evaluation sought to understand staff experiences of implementing PIFU. Methods: We conducted a rapid qualitative service evaluation between June 2022 and July 2023, based on semi-structured interviews (n = 36) with operational/managerial and clinical NHS staff from five English NHS Trusts, and an online workshop with 21 additional members of staff from the English NHS. We drew on the Non-adoption, Abandonment, Scale-up, Spread and Sustainability (NASSS) framework to structure qualitative data collection and analysis and to generate new insights into the adoption of the innovation of PIFU. Results: We found that implementation of PIFU affected staff roles, workload, and job satisfaction. Levels of PIFU uptake, and experience with similar models, affected the extent to which participants experienced the impact of PIFU. How PIFU was implemented varied. Some staff saw changes in their role because of new administrative demands, safety-netting procedures (such as proactive measures by specialty teams to mitigate the risk of patients not initiating appointments when necessary), and selection of suitable patients. PIFU was felt by some staff to increase, and by others to decrease, workload. PIFU affected intensity of work, interrelated with other factors such as the size of waiting lists, and conditions experienced by patients. Whether staff were satisfied with PIFU related to its impact on their role and workload. Satisfaction was also affected by whether staff believed PIFU delivered benefits for patients, and by the aims they felt were driving rollout. Conclusion: PIFU can significantly affect the experiences of staff and change staff roles and workload. However, the impact of PIFU is not uniform. Staff perspectives on PIFU from all parts of the health system should be better understood and considered during pathway design.
- Open Access
- 31 October 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e81421
Implementation, Experiences, Impact, and Costs of Artificial Intelligence in Chest Diagnostics: Protocol for a Mixed Methods Evaluation
Background: The ability to perform complex tasks has seen artificial intelligence (AI) used to support radiology in clinical settings, including lung cancer detection and diagnosis. Evidence suggests that AI can contribute to accurate diagnosis, reduce errors, and improve efficiency. The National Health Service England (NHSE)–funded Artificial Intelligence Diagnostic Fund (AIDF) is currently supporting 12 National Health Service (NHS) networks to implement AI for chest diagnostic imaging. There is, however, limited evidence on real-world AI implementation and use, including staff, patient, and caregiver experience, and costs and cost-effectiveness. A National Institute for Health and Care Research Rapid Service Evaluation Team Phase 1 evaluation provided insights into the early implementation of these tools and developed a framework for monitoring and evaluation of AI tools for chest diagnostic imaging in practice. Objective: This mixed methods evaluation of AI tools for chest diagnostic imaging aims to address previous research gaps by exploring the implementation of AI tools for chest diagnostic imaging, the impact and costs of implementing these service models, and the experiences of patients, caregivers, and staff. Methods: This study will be a mixed method evaluation of implementation, experiences, impact, and costs of AI for chest diagnostic imaging in NHS services in England, with the evaluation informed by the Major System Change Framework. Trust-level case studies (3 in-depth and up to 9 light-touch) will be performed, including staff member, patient, and caregiver; NHSE AIDF team interviews; meeting observations; and analysis of key relevant documentation. Qualitative data will be analyzed using Rapid Assessment Procedures and inductive thematic analysis, supplemented by in-depth deductive thematic analysis. Data from case study sites and other relevant sources will be used to assess outcomes at the other sites and for comparators. A pragmatic economic model of the chest diagnostic imaging pathway will be developed to estimate key costs and resource use associated with AI tool deployment. Together with input from national stakeholders and staff workshops, the study findings will then be finalized for reporting. Results: As of September 2025, trust-level research and development approvals with participating sites are complete, and data collection has commenced. Results are expected to be reported by the end of February 2026. Conclusions: The study will provide new insights into the facilitators and barriers to the adoption of AI technology in health care and the perceptions of both the general public and health care staff on its use. It will also inform best practices in approaches for service performance evaluation, for the implementation of AI into existing care pathways, and for the development of models to best support evidence-based decision-making. It will thus establish a framework upon which the greatest benefits of the use of AI in health care can be realized. International Registered Report Identifier (IRRID): DERR1-10.2196/81421
- 31 October 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e81421
Open AccessImplementation, Experiences, Impact, and Costs of Artificial Intelligence in Chest Diagnostics: Protocol for a Mixed Methods Evaluation
Background: The ability to perform complex tasks has seen artificial intelligence (AI) used to support radiology in clinical settings, including lung cancer detection and diagnosis. Evidence suggests that AI can contribute to accurate diagnosis, reduce errors, and improve efficiency. The National Health Service England (NHSE)–funded Artificial Intelligence Diagnostic Fund (AIDF) is currently supporting 12 National Health Service (NHS) networks to implement AI for chest diagnostic imaging. There is, however, limited evidence on real-world AI implementation and use, including staff, patient, and caregiver experience, and costs and cost-effectiveness. A National Institute for Health and Care Research Rapid Service Evaluation Team Phase 1 evaluation provided insights into the early implementation of these tools and developed a framework for monitoring and evaluation of AI tools for chest diagnostic imaging in practice. Objective: This mixed methods evaluation of AI tools for chest diagnostic imaging aims to address previous research gaps by exploring the implementation of AI tools for chest diagnostic imaging, the impact and costs of implementing these service models, and the experiences of patients, caregivers, and staff. Methods: This study will be a mixed method evaluation of implementation, experiences, impact, and costs of AI for chest diagnostic imaging in NHS services in England, with the evaluation informed by the Major System Change Framework. Trust-level case studies (3 in-depth and up to 9 light-touch) will be performed, including staff member, patient, and caregiver; NHSE AIDF team interviews; meeting observations; and analysis of key relevant documentation. Qualitative data will be analyzed using Rapid Assessment Procedures and inductive thematic analysis, supplemented by in-depth deductive thematic analysis. Data from case study sites and other relevant sources will be used to assess outcomes at the other sites and for comparators. A pragmatic economic model of the chest diagnostic imaging pathway will be developed to estimate key costs and resource use associated with AI tool deployment. Together with input from national stakeholders and staff workshops, the study findings will then be finalized for reporting. Results: As of September 2025, trust-level research and development approvals with participating sites are complete, and data collection has commenced. Results are expected to be reported by the end of February 2026. Conclusions: The study will provide new insights into the facilitators and barriers to the adoption of AI technology in health care and the perceptions of both the general public and health care staff on its use. It will also inform best practices in approaches for service performance evaluation, for the implementation of AI into existing care pathways, and for the development of models to best support evidence-based decision-making. It will thus establish a framework upon which the greatest benefits of the use of AI in health care can be realized. International Registered Report Identifier (IRRID): DERR1-10.2196/81421
- Open Access
- 28 October 2025
- Published by Elsevier in Public Health
- Vol. 249, 106007
Measuring the cost and effectiveness of peer-supported social care in prisons
- 28 October 2025
- Published by Elsevier in Public Health
- Vol. 249, 106007
Open AccessMeasuring the cost and effectiveness of peer-supported social care in prisons
- Open Access
- 28 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Implementation, Experiences, Impact, and Costs of Artificial Intelligence in Chest Diagnostics: Protocol for a Mixed Methods Evaluation (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The ability to perform complex tasks has seen artificial intelligence (AI) used to support radiology in clinical settings, including lung cancer detection and diagnosis. Evidence suggests that AI can contribute to accurate diagnosis, reduce errors, and improve efficiency. The National Health Service England (NHSE)–funded Artificial Intelligence Diagnostic Fund (AIDF) is currently supporting 12 National Health Service (NHS) networks to implement AI for chest diagnostic imaging. There is, however, limited evidence on real-world AI implementation and use, including staff, patient, and caregiver experience, and costs and cost-effectiveness. A National Institute for Health and Care Research Rapid Service Evaluation Team Phase 1 evaluation provided insights into the early implementation of these tools and developed a framework for monitoring and evaluation of AI tools for chest diagnostic imaging in practice. Objective: This mixed methods evaluation of AI tools for chest diagnostic imaging aims to address previous research gaps by exploring the implementation of AI tools for chest diagnostic imaging, the impact and costs of implementing these service models, and the experiences of patients, caregivers, and staff. Methods: This study will be a mixed method evaluation of implementation, experiences, impact, and costs of AI for chest diagnostic imaging in NHS services in England, with the evaluation informed by the Major System Change Framework. Trust-level case studies (3 in-depth and up to 9 light-touch) will be performed, including staff member, patient, and caregiver; NHSE AIDF team interviews; meeting observations; and analysis of key relevant documentation. Qualitative data will be analyzed using Rapid Assessment Procedures and inductive thematic analysis, supplemented by in-depth deductive thematic analysis. Data from case study sites and other relevant sources will be used to assess outcomes at the other sites and for comparators. A pragmatic economic model of the chest diagnostic imaging pathway will be developed to estimate key costs and resource use associated with AI tool deployment. Together with input from national stakeholders and staff workshops, the study findings will then be finalized for reporting. Results: As of September 2025, trust-level research and development approvals with participating sites are complete, and data collection has commenced. Results are expected to be reported by the end of February 2026. Conclusions: The study will provide new insights into the facilitators and barriers to the adoption of AI technology in health care and the perceptions of both the general public and health care staff on its use. It will also inform best practices in approaches for service performance evaluation, for the implementation of AI into existing care pathways, and for the development of models to best support evidence-based decision-making. It will thus establish a framework upon which the greatest benefits of the use of AI in health care can be realized. Trial Registration:
- 28 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImplementation, Experiences, Impact, and Costs of Artificial Intelligence in Chest Diagnostics: Protocol for a Mixed Methods Evaluation (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The ability to perform complex tasks has seen artificial intelligence (AI) used to support radiology in clinical settings, including lung cancer detection and diagnosis. Evidence suggests that AI can contribute to accurate diagnosis, reduce errors, and improve efficiency. The National Health Service England (NHSE)–funded Artificial Intelligence Diagnostic Fund (AIDF) is currently supporting 12 National Health Service (NHS) networks to implement AI for chest diagnostic imaging. There is, however, limited evidence on real-world AI implementation and use, including staff, patient, and caregiver experience, and costs and cost-effectiveness. A National Institute for Health and Care Research Rapid Service Evaluation Team Phase 1 evaluation provided insights into the early implementation of these tools and developed a framework for monitoring and evaluation of AI tools for chest diagnostic imaging in practice. Objective: This mixed methods evaluation of AI tools for chest diagnostic imaging aims to address previous research gaps by exploring the implementation of AI tools for chest diagnostic imaging, the impact and costs of implementing these service models, and the experiences of patients, caregivers, and staff. Methods: This study will be a mixed method evaluation of implementation, experiences, impact, and costs of AI for chest diagnostic imaging in NHS services in England, with the evaluation informed by the Major System Change Framework. Trust-level case studies (3 in-depth and up to 9 light-touch) will be performed, including staff member, patient, and caregiver; NHSE AIDF team interviews; meeting observations; and analysis of key relevant documentation. Qualitative data will be analyzed using Rapid Assessment Procedures and inductive thematic analysis, supplemented by in-depth deductive thematic analysis. Data from case study sites and other relevant sources will be used to assess outcomes at the other sites and for comparators. A pragmatic economic model of the chest diagnostic imaging pathway will be developed to estimate key costs and resource use associated with AI tool deployment. Together with input from national stakeholders and staff workshops, the study findings will then be finalized for reporting. Results: As of September 2025, trust-level research and development approvals with participating sites are complete, and data collection has commenced. Results are expected to be reported by the end of February 2026. Conclusions: The study will provide new insights into the facilitators and barriers to the adoption of AI technology in health care and the perceptions of both the general public and health care staff on its use. It will also inform best practices in approaches for service performance evaluation, for the implementation of AI into existing care pathways, and for the development of models to best support evidence-based decision-making. It will thus establish a framework upon which the greatest benefits of the use of AI in health care can be realized. Trial Registration:
- Open Access
- 23 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Delivering virtual wards at scale in LMICs: What can we learn from a qualitative exploration of a national virtual ward programme in the UK (Preprint)
BACKGROUND As the potential of virtual wards to offer safe cost-effective care at distance is becoming more widely understood, their international utilisation is growing for a range of conditions, despite the lack of robust, policy level principles for their design and delivery. Policymakers, commissioners and service leads in high-income-countries have the benefit of learning from numerous if localised initiatives, for those in low-and middle-income countries there are few previous examples to draw upon. However, with growing evidence that the key challenges of providing effective and equitable digital health are shared by health systems across the globe, it is possible that important lessons for low-income countries can be learnt from the experiences of those delivering virtual ward programmes in high-income countries. OBJECTIVE To collate the experiences of policymakers, clinical innovators and service providers of delivering a national virtual ward programme in the UK and place these findings in the context of low-and-middle-income-countries specifically for the purpose of providing practicable learning for those in low-and-middle-income settings. METHODS A directed content analysis using qualitative data collected from interviews with staff involved in developing, leading and delivering a national virtual ward programme (n=58) was used to populate the domains of the Non-adoption, Abandonment, and challenges to the Scale-up, Spread, and Sustainability of technologies for health and social care (NASSS) framework. RESULTS The NASSS framework provided transferable learning for those wishing to deliver VWs at scale in Low-and-middle-income-countries across its seven domains: Condition, the importance of having a process for accommodating new clinical evidence into the existing referral and treatment criteria; Technology, the need for robust and consistent supply lines, and greater provider engagement in digital procurement; Value proposition the benefits of unified (central) messaging on need and benefit to facilitate patient understanding and organisational buy-in; Adopters the need to understand the digital capabilities of patients and their carers, and the impact of remote working, especially on co-opted, inexperienced or untrained staff; Organisation, the value of prior experience of delivering similar services and existing collaborative inter-organisational partnerships; Wider system, the importance of national policies being structured to accommodate regional priorities and of leadership cultures that share best practice; Finally in Embedding over time the need to integrate systematic evaluation to inform iterative improvement incorporating, if not driven by, patient experience. CONCLUSIONS If virtual wards in low-and-middle-income-countries are to be successfully deployed at scale they need to overcome several challenges relating to the interaction of infrastructure, technology, patients, providers, and organisations as exemplified by the experience of implementing the national virtual ward programme in the United Kingdom. Building on our findings we have developed a series of questions to inform current and future policy design for national virtual ward programmes in low-and-middle-income-countries.
- 23 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDelivering virtual wards at scale in LMICs: What can we learn from a qualitative exploration of a national virtual ward programme in the UK (Preprint)
BACKGROUND As the potential of virtual wards to offer safe cost-effective care at distance is becoming more widely understood, their international utilisation is growing for a range of conditions, despite the lack of robust, policy level principles for their design and delivery. Policymakers, commissioners and service leads in high-income-countries have the benefit of learning from numerous if localised initiatives, for those in low-and middle-income countries there are few previous examples to draw upon. However, with growing evidence that the key challenges of providing effective and equitable digital health are shared by health systems across the globe, it is possible that important lessons for low-income countries can be learnt from the experiences of those delivering virtual ward programmes in high-income countries. OBJECTIVE To collate the experiences of policymakers, clinical innovators and service providers of delivering a national virtual ward programme in the UK and place these findings in the context of low-and-middle-income-countries specifically for the purpose of providing practicable learning for those in low-and-middle-income settings. METHODS A directed content analysis using qualitative data collected from interviews with staff involved in developing, leading and delivering a national virtual ward programme (n=58) was used to populate the domains of the Non-adoption, Abandonment, and challenges to the Scale-up, Spread, and Sustainability of technologies for health and social care (NASSS) framework. RESULTS The NASSS framework provided transferable learning for those wishing to deliver VWs at scale in Low-and-middle-income-countries across its seven domains: Condition, the importance of having a process for accommodating new clinical evidence into the existing referral and treatment criteria; Technology, the need for robust and consistent supply lines, and greater provider engagement in digital procurement; Value proposition the benefits of unified (central) messaging on need and benefit to facilitate patient understanding and organisational buy-in; Adopters the need to understand the digital capabilities of patients and their carers, and the impact of remote working, especially on co-opted, inexperienced or untrained staff; Organisation, the value of prior experience of delivering similar services and existing collaborative inter-organisational partnerships; Wider system, the importance of national policies being structured to accommodate regional priorities and of leadership cultures that share best practice; Finally in Embedding over time the need to integrate systematic evaluation to inform iterative improvement incorporating, if not driven by, patient experience. CONCLUSIONS If virtual wards in low-and-middle-income-countries are to be successfully deployed at scale they need to overcome several challenges relating to the interaction of infrastructure, technology, patients, providers, and organisations as exemplified by the experience of implementing the national virtual ward programme in the United Kingdom. Building on our findings we have developed a series of questions to inform current and future policy design for national virtual ward programmes in low-and-middle-income-countries.
- Open Access
- 1 January 2025
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- Vol. 13 (1) , 1-140
Peer support for adult social care in prisons in England and Wales: a mixed-methods rapid evaluation
Background: More adults in prison need social care support. In some prisons, prisoners (‘buddies’) are trained to provide social care support for non-personal care tasks to other prisoners. These services are not mandated but have been proposed as a solution to support social care provision in prisons. Previous research explored delivery of peer support initiatives in prisons, but there has been little research evaluating the effectiveness, implementation and experience of social care peer support. There is a need to establish how best to measure the impact and cost of peer support schemes for social care in prisons in England and Wales. Objective: To evaluate peer support schemes for adult social care in prisons in England and Wales (including implementation, experiences, risks and benefits, outcomes and costs, available data, and how to measure impact and cost). Methods: A rapid mixed-methods study, including a rapid systematic scoping review (n = 70 papers), a documentary analysis of 102 His Majesty’s Inspectorate of Prisons reports, and a multisite study of implementation and experience. The multisite study included 1 workshop with national and local stakeholders (n = 13) and 71 interviews with national and local leads (n = 7), prison leads from 18 prisons (n = 20), staff (n = 7), peers (n = 18) and recipients (n = 19) from 5 prisons. Qualitative analysis took place in two phases: (1) rapid analysis (using rapid assessment procedure sheets) and (2) in-depth thematic analysis. We analysed availability of data to measure impact and cost of services. Results: ‘Buddies’ are frequently used in prisons in England and Wales, filling an important gap in social care provision. Implementation varies, due to service, prison, staff and prisoner factors. Prison service instruction guidelines for peer-supported social care are not consistently being implemented. This study identified areas for improvement, for example the need for formal training for buddies and staff, and the need for clear standardised employment procedures. Buddy schemes are valued by staff, buddies and recipients. Some barriers were identified, for example, lack of peer and staff training and supervision, and prison regime. Peer-supported social care may have wide-reaching benefits, yet there are several risks for recipients and buddies that must be mitigated, including the potential for exploitation of the role by staff, buddies and recipients. It is currently not possible to evaluate impact and cost due to limited data. We have developed an evaluation guide which outlines operational, cost and outcome data that needs to be collected to enable regular monitoring and/or evaluation in future. Limitations: There is a lack of data collected on impact and cost, so we were unable to measure effectiveness and cost in this study. Instead, we developed an evaluation framework to inform future impact and cost evaluations. Future work: National standards for peer-supported social care (including national data infrastructure) would enable robust monitoring and evaluations of effectiveness and cost-effectiveness of peer support for social care. Conclusions: Peer support services are well received by different stakeholders, but standardisation is needed to ensure they are sufficiently resourced and appropriately monitored and evaluated to mitigate against risks. Study registration: This study is registered as researchregistry8783. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: NIHR135689) and is published in full in Health and Social Care Delivery Research; Vol. 13, No. 1. See the NIHR Funding and Awards website for further award information.
- 1 January 2025
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- Vol. 13 (1) , 1-140
Open AccessPeer support for adult social care in prisons in England and Wales: a mixed-methods rapid evaluation
Background: More adults in prison need social care support. In some prisons, prisoners (‘buddies’) are trained to provide social care support for non-personal care tasks to other prisoners. These services are not mandated but have been proposed as a solution to support social care provision in prisons. Previous research explored delivery of peer support initiatives in prisons, but there has been little research evaluating the effectiveness, implementation and experience of social care peer support. There is a need to establish how best to measure the impact and cost of peer support schemes for social care in prisons in England and Wales. Objective: To evaluate peer support schemes for adult social care in prisons in England and Wales (including implementation, experiences, risks and benefits, outcomes and costs, available data, and how to measure impact and cost). Methods: A rapid mixed-methods study, including a rapid systematic scoping review (n = 70 papers), a documentary analysis of 102 His Majesty’s Inspectorate of Prisons reports, and a multisite study of implementation and experience. The multisite study included 1 workshop with national and local stakeholders (n = 13) and 71 interviews with national and local leads (n = 7), prison leads from 18 prisons (n = 20), staff (n = 7), peers (n = 18) and recipients (n = 19) from 5 prisons. Qualitative analysis took place in two phases: (1) rapid analysis (using rapid assessment procedure sheets) and (2) in-depth thematic analysis. We analysed availability of data to measure impact and cost of services. Results: ‘Buddies’ are frequently used in prisons in England and Wales, filling an important gap in social care provision. Implementation varies, due to service, prison, staff and prisoner factors. Prison service instruction guidelines for peer-supported social care are not consistently being implemented. This study identified areas for improvement, for example the need for formal training for buddies and staff, and the need for clear standardised employment procedures. Buddy schemes are valued by staff, buddies and recipients. Some barriers were identified, for example, lack of peer and staff training and supervision, and prison regime. Peer-supported social care may have wide-reaching benefits, yet there are several risks for recipients and buddies that must be mitigated, including the potential for exploitation of the role by staff, buddies and recipients. It is currently not possible to evaluate impact and cost due to limited data. We have developed an evaluation guide which outlines operational, cost and outcome data that needs to be collected to enable regular monitoring and/or evaluation in future. Limitations: There is a lack of data collected on impact and cost, so we were unable to measure effectiveness and cost in this study. Instead, we developed an evaluation framework to inform future impact and cost evaluations. Future work: National standards for peer-supported social care (including national data infrastructure) would enable robust monitoring and evaluations of effectiveness and cost-effectiveness of peer support for social care. Conclusions: Peer support services are well received by different stakeholders, but standardisation is needed to ensure they are sufficiently resourced and appropriately monitored and evaluated to mitigate against risks. Study registration: This study is registered as researchregistry8783. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: NIHR135689) and is published in full in Health and Social Care Delivery Research; Vol. 13, No. 1. See the NIHR Funding and Awards website for further award information.
- Open Access
- 20 September 2024
- Published by Elsevier in Public Health
- Vol. 236, 412-421
Peer support for health, social care, and educational needs in adult prisons: a systematic scoping review
- 20 September 2024
- Published by Elsevier in Public Health
- Vol. 236, 412-421
Open AccessPeer support for health, social care, and educational needs in adult prisons: a systematic scoping review